Imodium Combo (Dimeticone, Loperamide Hydrochloride)

• Imodium Combo acts on the gastrointestinal tract to control diarrhea and relieve gas‑related discomfort.
• Acute diarrhea: reduces stool frequency, improves stool consistency, and helps restore fluid balance in adults with sudden onset diarrhoea.
• Travel‑associated diarrhea: provides rapid symptom control, decreasing urgency and dehydration risk for travelers in endemic regions.
• Bloating and flatulence: diminishes surface tension of intestinal gas bubbles, easing abdominal distension and discomfort.
• Chronic diarrhea: offers symptomatic reduction of stool output and improves quality of life for patients with persistent diarrhoeal conditions.
• Diarrhoea due to mild infections: helps control symptoms while underlying cause resolves.

• Loperamide Hydrochloride acts as a peripheral μ‑opioid receptor agonist in the myenteric plexus, decreasing intestinal smooth‑muscle activity, prolonging transit time and reducing fluid secretion. Dimeticone is a non‑systemic silicone polymer that lowers the surface tension of gas bubbles within the gastrointestinal lumen, facilitating coalescence and expulsion of gas, thereby alleviating bloating. The combined actions provide antidiarrheal effect together with relief of flatulence.

Imodium Combo may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Constipation: hard stools or difficulty passing stool.
• Abdominal cramps: mild to moderate cramping sensation.
• Nausea: feeling of queasiness.
• Dizziness: light‑headedness or vertigo.
• Dry mouth: reduced salivation.
• Flatulence: increased intestinal gas.

Serious or Rare Side Effects

• Severe constipation or intestinal obstruction: risk of ileus or toxic megacolon.
• Allergic reactions: rash, itching, swelling of face or throat.
• Cardiac effects: rare arrhythmias or QT prolongation, especially with high doses or interacting drugs.
• Severe abdominal pain: may indicate underlying pathology such as perforation.
• Hepatic enzyme elevation: uncommon increase in liver function tests.

Before using Imodium Combo, consider the following precautions to ensure safe and effective use.

• Age restriction: not recommended for children under 12 years without medical advice.
• Infectious diarrhoea: avoid use in diarrhoea caused by invasive bacteria or parasites.
• Abdominal pain: discontinue if severe abdominal pain or distension develops.
• Hepatic impairment: use with caution in patients with liver disease, as loperamide is metabolized hepatically.
• Drug interactions: review concomitant medications that may affect loperamide levels or cardiac rhythm.
• Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Imodium Combo can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma concentrations and risk of cardiac toxicity.
• Other antidiarrheal agents (e.g., diphenoxylate): additive effect on gut motility leading to severe constipation.
• Opioid analgesics: enhanced central opioid effects and respiratory depression risk.
• QT‑prolonging drugs (e.g., certain antiarrhythmics, macrolide antibiotics): increased chance of arrhythmias.
• MAO‑B inhibitors: may potentiate loperamide’s effects.

Moderate Interactions (Monitor Closely)

• Anticholinergic medications: combined effect may worsen constipation.
• Antihistamines or sedatives: may increase dizziness or drowsiness.
• Rifampicin: may reduce loperamide efficacy by inducing metabolism.
• Diuretics: monitor electrolyte balance as dehydration from diarrhoea may be exacerbated.
• Herbal supplements containing St. John’s wort: possible induction of CYP enzymes affecting loperamide levels.